Prospective Research: Funding, Investors & Team (Sep 2026)
Prospective Research is creating feed incorporated preventative disease management solutions for the aquaculture industry that completely removes the need for antibiotics and medicated feed. The company’s technology platform allows them to modulate bacterial behavior using microbial signaling molecules for the local delivery of therapeutics directly inside the gut of any farmed species. The company seeds trillions of bacterial pharmacies into the microbiome of fin-fish, shrimp, and shellfish, and can selectively turn on bacterial genes encoding bio-active therapeutics inside the animal for protection against bacterial, fungal, and parasitic pathogens.
Prospective Research has raised $200k across 1 funding round on record, the most recent a Debt Financing of $200k announced in Aug 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Prospective Research Company Profile and Key Stats
Latest funding round on record: Aug 2022.
Prospective Research Funding Rounds
Prospective Research Founders and Leadership Team
Contact details for the Prospective Research team: 1 of 1 has an email address on file.
Start 14-day free trial →Prospective Research Funding Compared to Other Biotechnology Startups
Prospective Research's latest round of $200k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Prospective Research in Biotechnology and Beverly
Companies Similar to Prospective Research
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Prospective Research Funding FAQs
What does Prospective Research do?
Prospective Research is creating feed incorporated preventative disease management solutions for the aquaculture industry that completely removes the need for antibiotics and medicated feed. The company’s technology platform allows them to modulate bacterial behavior using microbial signaling molecules for the local delivery of therapeutics directly inside the gut of any farmed species. The company seeds trillions of bacterial pharmacies into the microbiome of fin-fish, shrimp, and shellfish, and can selectively turn on bacterial genes encoding bio-active therapeutics inside the animal for protection against bacterial, fungal, and parasitic pathogens.
How much funding has Prospective Research raised?
Prospective Research has raised $200k across 1 round on record. The most recent is a Debt Financing of $200k announced in Aug 2022.
When did Prospective Research last raise funding?
Prospective Research's most recent funding round on record is a Debt Financing of $200k, announced in Aug 2022.
Who is the CEO of Prospective Research?
Dakota Hamill is listed as CEO at Prospective Research.
Where is Prospective Research headquartered?
Prospective Research is based in Beverly, Massachusetts, United States.
How many employees does Prospective Research have?
Prospective Research is in the 1-10 employee band.
How does Prospective Research's funding compare to other Biotechnology startups?
Prospective Research's latest round of $200k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Prospective Research Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Prospective Research is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.